Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Mc2 Therapeutics A/S

Headquarters: Hoersholm, Denmark
Year Founded: 2006
Status: Private

BioCentury | Oct 17, 2023
Deals

Oct. 16 Quick Takes: Novo turns to Singapore’s KBP for hypertension asset

Plus: Gout company Atom raises $83M and updates from AbbVie, BeiGene, Amgen, Daiichi and MoonLake
BioCentury | Oct 12, 2023
Product Development

MC2's Hsp90 inhibitor shows signs of efficacy in hidradenitis suppurativa

Readout sets up ‘first-in-class’ therapy for Phase IIb study in increasingly competitive inflammatory disease
BioCentury | Aug 31, 2023
Finance

Aug. 31 Quick Takes: Sage downsizes, reveals executive departures

Plus: CCM launches with $25M+ and updates from Kangpu, Clock Bio, MC2, Huadong and RabPharma
BioCentury | Jun 9, 2022
Management Tracks

Goldstein becomes president and CMO at Aurion

Plus Duke to be CFO at Apexigen and updates from MC2, Pillar, Nonagen and more
Items per page:
1 - 7 of 7